Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To investigate the impact of scaling-up opiate substitution therapy (OST) and high
coverage needle and syringe programmes (100%NSP-obtaining more sterile syringes than
you inject) on HCV prevalence among injecting drug users (IDUs).